Concepedia

Peiwei Yang

PY

Statistics

Publications

13

Citations

691

H-Index

13

Active since

2018

Affiliations

China Pharmaceutical University(Current)

Nanjing Medical University

Yueyang Hospital

Shanghai University of Traditional Chinese Medicine

Shanghai University

Peiwei Yang is an author at China Pharmaceutical University specializing in oncology, molecular oncology, and immunology.

Publications per year

2018–2024

13

Publications

13

Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

Erhao Zhang, Peiwei Yang, Jieyi Gu et al. · Journal of Hematology & Oncology · 2018 · 108 citations · Full text

Life Sciences, Immunology, Oncology +14

Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes

Ying Wang, Mengwei Li, Lin Chen et al. · Signal Transduction and Targeted Therapy · 2021 · 91 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12

Xiaowei Chi, Peiwei Yang, Erhao Zhang et al. · Cancer Medicine · 2019 · 78 citations · Full text

Life Sciences, Immunology, Oncology +17

Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas

Mengwei Li, Xu Ding, Yinan Zhang et al. · Cell Death and Disease · 2020 · 78 citations · Full text

Medicine, Cancer Biology, Oncology +17

Micropeptide MIAC Inhibits HNSCC Progression by Interacting with Aquaporin 2

Xin Li, Yinan Zhang, Heming Wu et al. · Journal of the American Chemical Society · 2020 · 64 citations

Medicine, Molecular Biology, Oncology +16

1–5 of 13